Literature DB >> 8348740

The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK.

M Hazlewood1, R Nusrat, D S Kumararatne, M Goodall, C Raykundalia, D G Wang, H J Joyce, A Milford-Ward, M Forte, A Pahor.   

Abstract

Antibody levels specific for capsular polysaccharides of Streptococcus pneumoniae and Haemophilus influenzae type b (Hib) and to tetanus toxoid (TT), were measured in serum samples of 750 age-stratified subjects from the UK. The study subjects comprised healthy adult volunteers and hospitalized children undergoing elective surgery, excluding those with a history of infection or under investigation for immunological or haematological disorders. These antibody levels were calibrated by comparison with serum pool obtained from healthy adult volunteers, who were immunized with Hib polyribose-phosphate vaccine (Merieux). The data are intended to provide reference ranges to assist in the interpretation of specific antibody measurements in the clinical setting. Maternal IgG pneumococcal capsular polysaccharide (PCP) specific antibody levels, geometric-mean titre (GMT) 1/22, were lost by 6 months of age (GMT of 1/9). They remained low until 3-5 years (GMT of 1/20), and consisted principally of IgG1. Thereafter, IgG anti-PCP antibody titres increased steadily to adult levels (GMT of 1/275), of which 80% was IgG2. Anti-PCP antibody titres of the IgM isotype rose steadily from a GMT 1/21 (0-6 months) to 1/420 (3-5 years), a level which was maintained until adulthood. Anti-Hib antibody concentrations, determined by RABA, again demonstrated the decline in maternal antibody, from 0.18 micrograms/ml in the 0-6 month age cohort, to 0.09 microgram/ml between 6 and 12 months. Geometric-mean antibody concentrations remained below 0.2 micrograms/ml until 3-5 years, then increased with age, attaining the mean adult level of 1.02 micrograms/ml. Anti-TT antibody concentrations were measured in the same sera, by ELISA. Two peaks in anti-TT antibody levels were seen in children of 0.059 IU/ml and 0.166 IU/ml corresponding to the schedule of routine childhood immunization in the first year and at 5 years of age.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8348740      PMCID: PMC1554852          DOI: 10.1111/j.1365-2249.1993.tb07959.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

Review 1.  The role of bacterial polysaccharide capsules as virulence factors.

Authors:  E R Moxon; J S Kroll
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

2.  Variability in the functional activity of vaccine-induced antibody to Haemophilus influenzae type b.

Authors:  J Amir; X Liang; D M Granoff
Journal:  Pediatr Res       Date:  1990-04       Impact factor: 3.756

3.  Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide.

Authors:  D M Musher; M J Luchi; D A Watson; R Hamilton; R E Baughn
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

4.  IgG subclasses in bacterial infections.

Authors:  L Hammarström; C I Smith
Journal:  Monogr Allergy       Date:  1986

5.  An immunodeficiency characterized by impaired antibody responses to polysaccharides.

Authors:  D M Ambrosino; G R Siber; B A Chilmonczyk; J B Jernberg; R W Finberg
Journal:  N Engl J Med       Date:  1987-03-26       Impact factor: 91.245

6.  Isotype concentrations of human antibodies to Haemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid).

Authors:  O Mäkelä; P Mattila; N Rautonen; I Seppälä; J Eskola; H Käyhty
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

Review 7.  Selective IgG subclass deficiency: quantification and clinical relevance.

Authors:  R Jefferis; D S Kumararatne
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

8.  An association between homozygous C3 deficiency and low levels of anti-pneumococcal capsular polysaccharide antibodies.

Authors:  M A Hazlewood; D S Kumararatne; A D Webster; M Goodall; P Bird; M Daha
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

9.  Comparisons of standard curve-fitting methods to quantitate Neisseria meningitidis group A polysaccharide antibody levels by enzyme-linked immunosorbent assay.

Authors:  B D Plikaytis; S H Turner; L L Gheesling; G M Carlone
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

10.  Prospects for prevention of Haemophilus influenzae type b disease by immunization.

Authors:  D M Granoff; R S Munson
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

View more
  12 in total

Review 1.  Anti-pneumococcal antibody titre measurement: what useful information does it yield?

Authors:  Paul Balmer; Andrew J Cant; Ray Borrow
Journal:  J Clin Pathol       Date:  2006-09-01       Impact factor: 3.411

2.  Characterization of the impaired antipneumococcal polysacharide antibody production in immunosuppressed pediatric patients following cardiac transplantation.

Authors:  A R Gennery; A J Cant; C I Baldwin; J E Calvert
Journal:  J Clin Immunol       Date:  2001-01       Impact factor: 8.317

3.  Antibody deficiency associated with gold treatment: natural history and management in 22 patients.

Authors:  N Snowden; D M Dietch; L S Teh; R C Hilton; M R Haeney
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

4.  Symptomatic IgG3 deficiency successfully treated with intravenous immunoglobulin therapy.

Authors:  J A Snowden; A Milford-Ward; J T Reilly
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401

5.  Quantification of IgM and IgA anti-pneumococcal capsular polysaccharides by a new ELISA assay: a valuable diagnostic and prognostic tool for common variable immunodeficiency.

Authors:  F M Cavaliere; C Milito; H Martini; M Schlesier; R Dräger; K Schütz; G Brunetti; A M Pesce; V Thon; K Warnatz; I Quinti
Journal:  J Clin Immunol       Date:  2012-12-29       Impact factor: 8.317

6.  Immunosuppressant effect of gold on IgG subclasses and IgE; evidence for sparing of Th2 responses.

Authors:  P D Kiely; M R Helbert; J Miles; D B Oliveira
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

7.  Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance.

Authors:  Johanna Karlsson; Björn Andréasson; Nahid Kondori; Evelina Erman; Kristian Riesbeck; Harriet Hogevik; Christine Wennerås
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

8.  Atopic eczema is associated with delayed maturation of the antibody response to pneumococcal vaccine.

Authors:  P D Arkwright; L Patel; A Moran; M R Haeney; C I Ewing; T J David
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

9.  Measurement and interpretation of pneumococcal IgG levels for clinical management.

Authors:  P Balmer; J North; D Baxter; E Stanford; A Melegaro; E B Kaczmarski; E Miller; R Borrow
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

10.  Two enzyme linked immunosorbent assays for detecting antibodies against meningococcal capsular polysaccharides A and C.

Authors:  O A Akinwolere; D S Kumararatne; R Bartlett; D M Goodall; D Catty
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.